Table 2 Study sub-groups’ flash glucose monitoring (FGM) data analysis, according to FGM profile No PBH (IFG < 54 mg/dl < 1%) and PBH (IFG < 54 mg/dl ≥ 1%), based on established criteria for level 2 hypoglycaemia.

From: Use of flash glucose monitoring for post-bariatric hypoglycaemia diagnosis and management

FGM evaluation analysis

No PBH

PBH

p value

N (% of total)

5 (38.5%)

8 (61.5%)

Duration (days)

11.87 (11.78–11.91)

11.90 (11.80–11.95)

0.524

Valid readings (N)

1,115 (1,103–1,123)

1,104 (1,039–1,131)

0.803

Data capture rate (%)

98.83 (97.71–99.51)

97.39 (91.36–99.42)

0.284

MAG change (mmol/l × h−1)

2.8 (2.3–2.9)

2.2 (1.6–2.9)

0.354

LBGIFGMGT

3.0 (2.6–3.6)

13.0 (11.6–18.1)

0.002

HBGIFGMGT

2.6 (1.8–3.2)

0.8 (0.4–2.1)

0.045

ADRRFGMGT

50.2 (39.1–56.1)

85.8 (70.2–91.2)

0.003

CONGA1

2.5 (2.0–2.6)

1.9 (1.4–2.6)

0.354

MODD

1.5 (1.1–1.8)

1.2 (0.9–1.5)

0.171

  1. Results are presented as median (interquartile range).
  2. PBH post-bariatric hypoglycaemia, MAG change mean absolute glucose change, LBGIFGMGT low blood glucose index (adjusted), HBGIFGMGT high blood glucose index (adjusted), ADRRFGMGT average daily risk ratio (adjusted), CONGA1 continuous overlapping net glycaemic action, MODD mean of daily differences.
  3. p values representative of statistically significant differences (p < 0.05) were highlighted in bold.